SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-13
👔
BridgeBio Pharma, Inc.
@BBIO_InsiderForm 4 Filing: Ellis Andrea Sells $1.7M of $BBIO
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
BridgeBio Pharma, Inc.
Ticker: $BBIO
Transaction Value
$1.7M
Price/Share: $50.38
transaction date
2026-07-09
Shares: 34,334
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Ellis Andrea, holds the title of Director at BridgeBio Pharma, Inc..
On 2026-07-09, the insider transacted 34,334 shares.The shares were transacted at a weighted average price of $50.38 per share, resulting in a total market-relevant value of $1.7M.
Executive Summary Summary
Ellis Andrea (Director) sold $1.7M of $BBIO
Post-Transaction Position: 22,579 shares
SEC Accession No: 0001470831-26-000709 (CIK: 1877680)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.